Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Short-term Investments (2016 - 2025)

Healthstream (HSTM) has disclosed Short-term Investments for 16 consecutive years, with $20.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-term Investments fell 44.78% to $20.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.8 million, a 44.78% decrease, with the full-year FY2025 number at $20.8 million, down 44.78% from a year prior.
  • Short-term Investments was $20.8 million for Q4 2025 at Healthstream, down from $39.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $39.0 million in Q3 2025 to a low of $2.0 million in Q2 2022.
  • A 5-year average of $20.9 million and a median of $24.3 million in 2023 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: plummeted 88.06% in 2021, then skyrocketed 1407.9% in 2023.
  • Healthstream's Short-term Investments stood at $5.0 million in 2021, then surged by 56.42% to $7.9 million in 2022, then skyrocketed by 290.62% to $30.8 million in 2023, then rose by 22.56% to $37.7 million in 2024, then plummeted by 44.78% to $20.8 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Short-term Investments are $20.8 million (Q4 2025), $39.0 million (Q3 2025), and $38.5 million (Q2 2025).